Coming soon: new IV cephalosporin active against MRSA CVS Caremark to acquire Longs Drug Stores “Non-dairy” acidophilus products: milk allergy warning Uncertainty regarding ezetimibe and cancer risk Practice Issues: Eye on Technology - The medication-use cycle Systems and technologies that can be used to reduce error rates in prescription and transcription stages. Practice Issues: Adverse Reactions - ESAs for cancer-related anemia Trials assess ESA use for the treatment of anemia among patients with cancer. Editorial: Blue skies ahead Blueprint for Pharmacy a chance to collectively move the profession forward. Chronic disease management report highlights collaboration Saskatchewan project largest of its kind in Canada. Practice Issues: Adverse Reactions - SSRIs and bleeding risk Two papers investigate effects of SSRIs and bleeding risk. Drug News: July/August 2008 Stalevo: new combo for Parkinson’s disease; Vectibix for colorectal cancer. First Previous 2364 2365 2366 2367 2368 Next Last
